Karolinska Universitetssjukhuset Huddinge

Huddinge SE-14186

6 studies enrolling now · 10 studies all time

What they study most

Alpha1-Antitrypsin Deficiency, COVID-19 Infection, Cerebrovascular Disease, Hepatitis Delta Virus, Intracerebral Haemorrhage, Intracerebral Hemorrhage, Intraventricular Hemorrhage, Metabolic Dysfunction-Associated Steatotic Liver Disease, Multifocal Motor Neuropathy, Neurodegenerative Diseases, Relapsed or Refractory Multiple Myeloma (RRMM), Stroke

Studies at this site

• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) — Recruiting now
• International Care Bundle Evaluation in Cerebral Hemorrhage Research — Recruiting now
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy — Running, not enrolling
• Continuation Study for Latozinemab — Stopped early
• Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a — Completed
• Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients — Completed